Thomas to Retire from IMS Chair

IMS Health has named David R. Carlucci as its Chairman, effective from April 1, in addition to his existing roles as CEO and President. Carlucci, 51, succeeds David M. Thomas, 56, who is retiring from the IMS Health Board of Directors at the same time.

Thomas served as Chairman and CEO of IMS from November 2000 until January 2005, when he assumed the role of Executive Chairman. He describes Carlucci as 'an exceptional executive who I am confident will continue to accelerate our growth and expand IMS's value to its clients. He has played a prominent role in broadening IMS's information, analytics and consulting capabilities worldwide.'

Carlucci joined IMS as President and COO in October 2002, and was named CEO and President in January 2005. His achievements since include realignment of the company's global marketing function, enhancing global sales account management and building IMS's consulting and services capabilities across all regions. He previously spent 26 years at IBM, where he rose to the position of General Manager, IBM Americas. He holds a B.A. in political science from the University of Rochester and serves on the advisory board of Mitsui USA, America's Group.

Also yesterday, IMS announced that the company's Board of Directors has voted to terminate its 'poison pill' shareholder rights plan, and establish a new policy that requires shareholder approval for any further shareholder rights plan either prior to, or within twelve months of adoption. Carlucci said the decision 'reflects our ongoing commitment and responsiveness to our shareholders'.

IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, with $1.8 billion in 2005 revenue. It is online at www.imshealth.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• IMS Health Inc
• All news